SCHEDULE: Third Point Discloses 5.8% Stake in Strata Medical

Third Point LLC and Daniel S. Loeb have disclosed a 5.8% beneficial ownership stake in Strata Critical Medical, Inc. through a Schedule 13G filing.

Summary

• Third Point LLC and Daniel S. Loeb collectively reported beneficial ownership of 5,000,000 shares of Common Stock in Strata Critical Medical, Inc.
• This ownership represents 5.8% of Strata Critical Medical, Inc.'s outstanding Common Stock.
• The percentage is calculated based on 86,366,526 shares of Common Stock outstanding as of November 3, 2025, as reported by the Issuer in its Form 10-Q.
• The reporting persons, Third Point LLC and Daniel S. Loeb, share both voting and dispositive power over all 5,000,000 shares.
• The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: The disclosure of a significant 5.8% stake by a prominent investment firm like Third Point LLC, even if not for control, can be perceived as a positive signal by the market, indicating a notable investor's interest in the company.

Positives

• Disclosure of a significant 5.8% stake by Third Point LLC and Daniel S. Loeb, a prominent investment firm, indicates institutional interest in Strata Critical Medical, Inc.

Negatives

• The filing does not contain information typically categorized as negatives related to the issuer's operational or financial performance.

Risks

• The filing does not detail specific risks related to Strata Critical Medical, Inc.'s operations or financial health.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding Strata Critical Medical, Inc.'s future performance or strategic plans.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing is a specific disclosure of a significant ownership stake by an investment firm in a single company. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• NA

Related Party Transactions

• NA

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor's stake may influence market perception and potentially the share price of Strata Critical Medical, Inc.

Next Steps

• The filing itself does not specify any future actions, events, or milestones for Strata Critical Medical, Inc. or the reporting persons beyond the disclosure requirement.

Key Dates

Keywords

Strata Critical Medical, Third Point LLC, Daniel S. Loeb, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, SEC Filing